Safety and Efficacy of KSVCBD Injection in Multiple Myeloma Expressing CD19 and/or BCMA
Clinical trial NCT07620275 · RECRUITING
Trial details
- NCT number
- NCT07620275
- Sponsor
- Chinese PLA General Hospital
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-10
- Primary completion
- 2028-12-15
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.